13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 14 managers

Reported value

$44.3M

Holders

14

+1 new · −2 exited

Holders’ est. mark

−$2.49M

Price effect on 9 books still in the name

Largest holder

$25.2M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC836.1K$25.2M−$217.4KAdded$5.45M
DANSKE BANK A/S108.5K$5.96M−$1.33MCut−$14K
Swiss Life Asset Management Ltd74.6K$4.1M−$259.3KAdded$2.93M
Alberta Investment Management Corp73.2K$4.02MHeld
PEAK6 LLC35K$1.92MHeld
OP Asset Management Ltd22.6K$1.24M−$322.4KCut−$205.5K
Essential Partners LLC18.3K$1.01MHeld
Sanctuary Advisors, LLC6.38K$350.5K−$47KAdded$139.1K
Leonteq Securities AG4.77K$262K−$75.7KCut−$98.3K
Burton Enright Welch3.67K$202K−$57.8KCut−$57.7K
VIRTUS ADVISERS, LLC35K$32.9K−$185KCut−$202.9K
ELEVATION POINT WEALTH PARTNERS, LLC172$9.46KNew
Prestige Wealth Management Group LLC34$1.87K−$535Cut−$3.5K

Who left

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.